Gaps in patient-physician communication at the time of malignant bowel obstruction from recurrent gynecologic cancer: a qualitative study.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 03 03 2021
accepted: 13 07 2021
pubmed: 22 7 2021
medline: 15 12 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

We sought to investigate the patient and physician approaches to malignant bowel obstruction (MBO) due to recurrent gynecologic cancer by (1) comparing patient and physician expectations and priorities during a new MBO diagnosis, and (2) highlighting factors that facilitate patient-doctor communication. Patients were interviewed about their experience during an admission for MBO, and physicians were interviewed about their general approach towards MBO. Interviews were analyzed for themes using QDAMiner qualitative analysis software. The analysis utilized the framework analysis and used both predetermined themes and those that emerged from the data. We interviewed 14 patients admitted with MBO from recurrent gynecologic cancer and 15 gynecologic oncologists. We found differences between patients and physicians regarding plans for next chemotherapy treatments, foremost priorities, communication styles, and need for end-of-life discussions. Both patients and physicians felt that patient-physician communication was improved in situations of trust, understanding patient preferences, corroboration of information, and increased time spent with patients during and before the MBO. Gaps in patient-physician communication could be targeted to improve the patient experience and physician counseling during a difficult diagnosis. Our findings emphasize a need for patient-physician discussions to focus on expectations for future cancer-directed treatments, support for patients at home with home health or hospice level support in line with their wishes, and acknowledgement of uncertainty while providing direct information about the MBO diagnosis.

Identifiants

pubmed: 34287689
doi: 10.1007/s00520-021-06441-0
pii: 10.1007/s00520-021-06441-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-376

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Hoppenot C, Peters P, Cowan M, Moore ED, Hurteau J, Lee NK et al (2019) Malignant bowel obstruction due to uterine or ovarian cancer: are there differences in outcome? Gynecol Oncol 154:177–182
doi: 10.1016/j.ygyno.2019.04.681
Lilley EJ, Scott JW, Goldberg JE, Cauley CE, Temel JS, Epstein AS et al (2018) Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: comparative study of surgery, venting gastrostomy, or medical management. Ann Surg 267(4):692–699
Mooney SJ, Winner M, Hershman DL, Wright JD, Feingold DL, Allendorf JD et al (2013) Bowel obstruction in elderly ovarian cancer patients: a population-based study. Gynecol Oncol 129:107–112
doi: 10.1016/j.ygyno.2012.12.028
Perri T, Korach J, Ben-Baruch G, Jakobson-Setton A, Ben-David Hogen L, Kalfon S et al (2014) Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention. Eur J Surg Oncol 40:899–904
doi: 10.1016/j.ejso.2013.10.025
Olson TJP, Pinkerton C, Brasel KJ, Schwarze ML (2014) Palliative surgery for malignant bowel obstruction from carcinomatosis: a systematic review. JAMA 149:383–392
Cusimano MC, Sajewycz K, Nelson M, Jivraj N, Lee YC, Bowering V et al (2020) Supported self-management as a model for end-of-life care in the setting of malignant bowel obstruction: a qualitative study. Gynecol Oncol 157(3):745–753
Back A, Anderson WG, Bunch L, Marr LA, Wallace J, Yang H et al (2008) Communication about cancer near the end of life. Cancer 113:1897–1910
doi: 10.1002/cncr.23653
Hagerty R, Butow P, Ellis P, Lobb E, Pendlebury S, Leighl N et al (2005) Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol 23(6):1278–88
Mays N, Pope C (2000) Qualitative research in health care. Assessing quality in qualitative research. BMJ 320:50–52
doi: 10.1136/bmj.320.7226.50
Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320:114–116
doi: 10.1136/bmj.320.7227.114
Ritchie JSL (1994) Qualitative data analysis for applied policy research. Routledge, London
doi: 10.4324/9780203413081_chapter_9
Mays N, Pope C (1995) Qualitative research: observational methods in health care settings. BMJ 311:182–184
doi: 10.1136/bmj.311.6998.182
Diver E, O’Connor O, Garrett L, Boruta D, Goodman A, Del Carmen M et al (2013) Modest benefit of total parenteral nutrition and chemotherapy after venting gastrostomy tube placement. Gynecol Oncol 129:332–335
doi: 10.1016/j.ygyno.2013.02.002
Lee YC, Jivraj N, Wang L, Chawla T, Lau J, Croke J et al (2019) Optimizing the care of malignant bowel obstruction in patients with advanced gynecologic cancer. J Oncol Pract 15(12):e1066–e1075
Ghodraty Jabloo V, Alibhai SMH, Fitch M, Tourangeau AE, Ayala AP, Puts MTE (2017) Antecedents and outcomes of uncertainty in older adults with cancer: a scoping review of the literature. Oncol Nurs Forum 44:E152–E167
doi: 10.1188/17.ONF.E152-E167
Bernacki RE, Block SD, American College of Physicians High Value Care Task F (2014) Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 174:1994–2003
doi: 10.1001/jamainternmed.2014.5271
Dean M, Davidson LG (2018) Previvors’ uncertainty management strategies for hereditary breast and ovarian cancer. Health Commun 33:122–130
doi: 10.1080/10410236.2016.1250187
Taylor LJ, Nabozny M, Steffens N, Brasel K, Johnson S, Zelenski A et al (2017) A framework to improve surgeon communication in high-stakes surgical decisions: best case/worst case. JAMA Surg 152:531–538
doi: 10.1001/jamasurg.2016.5674
Hoppenot C, Hlubocky FJ, Chor J, Yamada SD, Lee NK (2020) Approach to palliative care consultation for patients with malignant bowel obstruction in gynecologic oncology: a qualitative analysis of physician perspectives. JCO Oncol Pract 16(8):483–489
Stacey D, Legare F, Lewis K, Barry MJ, Bennett CL, Eden KB et al (2017) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 4:CD001431
pubmed: 28402085
Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL et al (1996) Patients’ preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol 62:329–335
doi: 10.1006/gyno.1996.0244

Auteurs

Claire Hoppenot (C)

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL, USA. Claire.hoppenot@bcm.edu.
Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Baylor College of Medicine, Dan L Duncan Comprehensive Cancer Center, 7200 Cambridge St., Houston, TX, 77030, USA. Claire.hoppenot@bcm.edu.

Fay J Hlubocky (FJ)

Section of Hematologic Oncology, Program for Supportive Oncology, Department of Medicine, University of Chicago Medical Center, Chicago, IL, USA.

Julie Chor (J)

Section of Family Planning and Contraceptive Research, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL, USA.

S Diane Yamada (SD)

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL, USA.

Nita K Lee (NK)

Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Chicago Medical Center, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH